Q&A with Manu Nair
OMRF official sees part of job
as commercializing technologies
Q: You most recently worked for the prestigious Mayo Clinic. Why did you leave there to join the Oklahoma Medical Research Foundation?
A: It may not be as well known in Oklahoma, but OMRF is prestigious too. In the world of biotherapeutics, OMRF is known around the world for the caliber of our researchers and the quality of work our scientists do. The foundation has a strong portfolio of discoveries that are ripe for commercialization. I’m looking forward to building a team and finding development partners so we can put OMRF breakthroughs to work benefiting patients.
Q: What did you learn at Mayo that can be replicated at OMRF?
A: I learned that technology ventures have to be run as a proactive business. At the Mayo Clinic, they look at technologies as they come in and make patenting decisions based on commercial potential. They have a “cradle-to-grave” model with the infrastructure to move discoveries from the lab to the market. Oklahoma has some of the pieces in place to do the same thing. We need to fill in the gaps so we can become a true competitor.